Jane L Parry Clinical Oncology Society of Australia 2014 Annual Scientific Meeting

Abstracts this author is presenting:

• Survival times of patients with metastatic non-small cell lung cancer (NSCLC) starting first-line chemotherapy in routine clinical practice versus contemporary randomised trials — Poster discussion 1